6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Just now	AerSale Reports First Quarter 2026 Results
Just now	Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
Just now	Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
Just now	SiriusPoint Reports First Quarter 2026 Net Income of $100m, Return on Equity of 17.4% and Operating Return on Equity of 15.3%

About

Proteomics International Laboratories Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Proteomics Strategic Plan

Restructure, Executive Appointment and Board Update

Appendix 4D and Interim Financial Report

Quarterly Activities/Appendix 4C Cash Flow Report

Canadian patent secured for PromarkerEso test for EAC

Recent Videos

Proteomics International Valuation | Mispricing The $152M Launch

Proteomics International Valuation | Mispricing The $152M Launch

Apr 29, 2026

Proteomics: Using advanced protein analysis to detect serious diseases

Proteomics: Using advanced protein analysis to detect serious diseases

Mar 05, 2026

Proteomics International (ASX:PIQ) The Stock Network's ASX Gems Investment Conference

Proteomics International (ASX:PIQ) The Stock Network's ASX Gems Investment Conference

Jan 21, 2026

Proteomics International (ASX:PIQ): The Stock Network's ASX Gems Investment Conference

Proteomics International (ASX:PIQ): The Stock Network's ASX Gems Investment Conference

Dec 22, 2025

Community Chat

Ask AI